Prtk stock price target

Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. Historical Ratings The table shows the mean historical analyst recommendation for the current period, along with the previous 1, 2, and 3 periods. 2 Stocks That Are Just Getting Started: Valley National ...

PRTK Price Target - ETF Channel The median PRTK price target (a different metric than the average or mean) was $20.0 as of 2019-08-21, the highest PRTK price target in the range was $44.0 while the lowest PRTK price target in the range was $7.0, with a standard deviation of $10.476. Paratek Pharmaceuticals, Inc. Common Stock (PRTK) Analyst ... Mar 20, 2020 · Based on analysts offering 12 month price targets for PRTK in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. PRTK - Paratek Pharmaceuticals Inc Stock quote -

Their average twelve-month price target is $17.20, suggesting that the stock has a possible upside of 345.60%. The high price target for PRTK is $36.00 and the 

5 Mar 2020 This is why professional analysts have recent PRTK price targets as revenue multiples to PRTK's stock when PRTK has provided FY2020  11 Mar 2020 Analysts Offer Insights on Healthcare Companies: InspireMD (NYSE MKT: NSPR) and Paratek Pharmaceuticals (NASDAQ: PRTK). By Ryan Adsit Bernardino covers the Healthcare sector, focusing on stocks such as Citius  PRTK: Get the latest Paratek Pharmaceuticals stock price and detailed information including PRTK news, historical charts and realtime prices. 3 Mar 2020 Some love them for their low share price and the possibility for huge returns, PRTK stock is up nearly 30% in the last week to $4.50 and is fast  30 Aug 2019 Analysts are surprisingly bullish on PRTK stock Healthcare stocks Paratek Pharmaceuticals Inc (NASDAQ:PRTK) and Akari Therapeutics 

Checking the True Picture for Paratek Pharmaceuticals, Inc ...

Jan 10, 2020 · Paratek Pharmaceuticals, Inc. [PRTK] has 33.88M shares outstanding, amounting to a total market cap of $145.35M. Its stock price has been found in the range of 2.66 to 7.39. At its current price, it has moved down by -41.95% from its 52-week high, and it … Analyst Ratings for Paratek Pharmaceuticals (PRTK) UPDATE: Paratek Pharmaceuticals (PRTK) PT Lowered to $26 at Guggenheim BofA/Merrill Lynch Starts Paratek Pharmaceuticals (PRTK) at Neutral BTIG Maintains Bullish View on Paratek Pharmaceuticals

Just Reported Yearly Earnings And Analysts Are Lifting Their Estimates. The investors in Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) will be rubbing their 

Raymond James Initiates Coverage On Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) to Strong Buy with a price target of $36. Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) currently has a consensus Price Target of $31.5. While some analysts have a High Price target for the stock of $56 and a Low Price Target …

Get the latest Paratek Pharmaceuticals, Inc. PRTK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Paratek Pharmaceuticals, Inc. - PRTK - Stock Price Today - Zacks PRTK is

PRTK Stock Price & Charts | Paratek Pharmaceuticals In depth view into PRTK (Paratek Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. PARATEK PHARMACEUTICALS, INC. : PRTK Stock Price ... Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry. Paratek Pharmaceuticals, Inc. (PRTK) Stock Price, Quote ... Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the Biomedical Advanced Research and Development

Paratek Pharmaceuticals Price Target Upside (Daily) | PRTK View Price Target Upside (Daily) for PRTK Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Start your free 7-Day Trial.